RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Clinical trials for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Myeloma drug combo trial halted after only 2 patients
Disease control TerminatedThis study tested a new oral drug called narazaciclib combined with dexamethasone in people with multiple myeloma that returned or didn't respond to treatment. The goal was to find a safe dose and see if it could shrink the cancer. Only 2 patients were enrolled before the study w…
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Adriana Rossi • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Experimental drug AMG 420 tested in Tough-to-Treat myeloma – early trial halted
Disease control TerminatedThis early-phase trial tested a drug called AMG 420 in 23 people with multiple myeloma that had returned or stopped responding to at least three prior treatments. Participants received the drug as a continuous 28-day IV infusion. The study aimed to find the safest dose and check …
Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 26, 2026 16:30 UTC